Anwar Arfidin, Sun Pengfei, Rong Xiaoxu, Arkin Abdulaziz, Elham Aliya, Yalkun Zilala, Li Xun, Iminjan Mubarak
Department of Pharmaceutics and Physical Chemistry, College of Pharmacy, Xinjiang Medical University, Urumqi, 830017, China.
University of Wisconsin-Madison, Department of Educational Psychology, Madison, USA.
Heliyon. 2023 Apr 23;9(5):e15753. doi: 10.1016/j.heliyon.2023.e15753. eCollection 2023 May.
Nowadays, among 3rd generation drug delivery systems, biodegradable polymeric based long-acting injectable depot has achieved tremendous success in clinical application. So far, there have been two dozen of commercial products of Poly (lactic-co-glycolic acid) microspheres available in the market. Recently, continuous manufacturing concept has been successfully applied on oral solid formulation from buzzword to reality. However, the polymeric injectable microspheres are still stayed at batch manufacturing phase due to the lack of understanding of knowledge matrix. In this study, micro-mixer as a plug-and-play emulsification modules, Raman spectroscopy and focused beam reflectance measurement as real-time monitoring modules are integrated into a novel semi-continuous manufacturing streamline to provides more efficient upscaling flexibility in microspheres production. In this end to end semi-continuous manufacturing process, amphiphilic block polymer monomethoxy-poly (ethylene glycol) modified PLGA (mPEG-PLGA) was used for encapsulating Gallic acid. Additionally, with guarantee of good robustness, the correlation relationship between critical process parameters, critical material attributes and critical quality attributes were investigated. The time-space evolution process and mechanism for formation of PEG-PLGA microsphere with particular morphology were elaborated. Altogether, this study firstly established semi-continuous manufacturing streamline for PLGA/PEG-PLGA microspheres, which would not only lower the cost of production, narrow process variability and smaller equipment/environmental footprint but also applied in-process control (IPC) and QbD principle on complicated production process of microspheres. Therefore, this study build confidence in the industrial development of PLGA/PEG-PLGA microspheres and establish best practice standards, which might be a quantum leap for developing PLGA microspheres in the future.
如今,在第三代药物递送系统中,基于可生物降解聚合物的长效注射储库在临床应用中取得了巨大成功。到目前为止,市场上已有二十多种聚(乳酸-共-乙醇酸)微球的商业产品。最近,连续制造概念已成功地从流行语应用于口服固体制剂并成为现实。然而,由于对知识矩阵缺乏了解,聚合物注射微球仍停留在批量生产阶段。在本研究中,微混合器作为即插即用的乳化模块,拉曼光谱和聚焦光束反射测量作为实时监测模块被集成到一条新型的半连续制造流线中,以在微球生产中提供更高效的放大灵活性。在这个端到端的半连续制造过程中,两亲性嵌段聚合物单甲氧基-聚(乙二醇)修饰的聚乳酸-羟基乙酸共聚物(mPEG-PLGA)被用于包封没食子酸。此外,在保证良好稳健性的情况下,研究了关键工艺参数、关键物料属性和关键质量属性之间的相关关系。阐述了具有特定形态的PEG-PLGA微球形成的时空演化过程及机理。总之,本研究首次建立了PLGA/PEG-PLGA微球的半连续制造流线,这不仅会降低生产成本、缩小工艺变异性和减少设备/环境足迹,而且还将过程控制(IPC)和质量源于设计(QbD)原则应用于微球复杂的生产过程。因此,本研究增强了对PLGA/PEG-PLGA微球产业发展的信心并建立了最佳实践标准,这可能是未来开发PLGA微球的一次巨大飞跃。